Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme 1 selected

Guidance programme

Showing 51 to 75 of 757

TitleReference numberPublishedLast updated
Asciminib for treating chronic myeloid leukaemia after 2 or more tyrosine kinase inhibitorsTA813
Atezolizumab for adjuvant treatment of resected non-small-cell lung cancerTA823
Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapyTA520
Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapyTA525
Atezolizumab for untreated PD-L1-positive advanced urothelial cancer when cisplatin is unsuitableTA739
Atezolizumab in combination for treating metastatic non-squamous non-small-cell lung cancerTA584
Atezolizumab monotherapy for untreated advanced non-small-cell lung cancerTA705
Atezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinomaTA666
Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancerTA638
Atezolizumab with carboplatin and nab-paclitaxel for untreated advanced non-squamous non-small-cell lung cancer (terminated appraisal)TA618
Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancerTA639
Atogepant for preventing migraineTA973
Autologous chondrocyte implantation for treating symptomatic articular cartilage defects of the kneeTA477
Autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the kneeTA508
Avacopan for treating severe active granulomatosis with polyangiitis or microscopic polyangiitisTA825
Avalglucosidase alfa for treating Pompe diseaseTA821
Avapritinib for treating unresectable or metastatic gastrointestinal stromal tumours (terminated appraisal)TA730
Avatrombopag for treating primary chronic immune thrombocytopeniaTA853
Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedureTA626
Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapyTA788
Avelumab for treating metastatic Merkel cell carcinomaTA517
Avelumab for untreated metastatic Merkel cell carcinomaTA691
Avelumab with axitinib for untreated advanced renal cell carcinomaTA645
Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapiesTA872
Axicabtagene ciloleucel for treating relapsed or refractory diffuse large B-cell lymphoma after first-line chemoimmunotherapyTA895

Results per page

  1. 10
  2. 25
  3. 50
  4. All